178 related articles for article (PubMed ID: 17537309)
21. [Establishment of cisplatin-resistant human endometrial cancer cell line and the study of its resistant mechanisms].
Xu QY; Chen YH; Zhao LJ; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):533-7. PubMed ID: 22041447
[TBL] [Abstract][Full Text] [Related]
22. [Chemosensitivity test on hepatocellular carcinoma (HCC) and drug resistance].
Ishimura H
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):689-98. PubMed ID: 8996838
[TBL] [Abstract][Full Text] [Related]
23. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
24. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
[TBL] [Abstract][Full Text] [Related]
25. [Establishment of a cisplatin-resistant human cervical cancer cell line].
Chen XL; Wang H; Zhang XM; Liu HQ; Liu SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):151-5. PubMed ID: 22650020
[TBL] [Abstract][Full Text] [Related]
26. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
27. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
Ueda M; Misaki O; Yamada T; Okamoto Y; Goto M; Maeda T; Okamura S; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1423-30. PubMed ID: 2531191
[TBL] [Abstract][Full Text] [Related]
28. Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assay.
Hightower RD; Sevin BU; Perras JP; Untch M; Angioli R; Ramos R; Averette H
Gynecol Oncol; 1992 Nov; 47(2):186-90. PubMed ID: 1468696
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].
Han J; Tan BB; Geng W; Lu BR; Zhao JH
Ai Zheng; 2008 Nov; 27(11):1166-71. PubMed ID: 19000447
[TBL] [Abstract][Full Text] [Related]
30. [ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer].
Zhang Y; Zhao Q; Jiang Y; Yuan Z; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1223-7. PubMed ID: 24384959
[TBL] [Abstract][Full Text] [Related]
31. [Expression features of P-glycoprotein, glutathione S transferase-pi and inhibitor of apoptosis proteins in lymph node metastases of gastrointestinal carcinomas].
Han J; Tan BB; Wang AF; Lü BR; Geng W; Zhao JH; He CN
Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):106-8. PubMed ID: 19563003
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA).
Whitehouse PA; Knight LA; Di Nicolantonio F; Mercer SJ; Sharma S; Cree IA;
Anticancer Drugs; 2003 Jun; 14(5):369-75. PubMed ID: 12782944
[TBL] [Abstract][Full Text] [Related]
33. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
[TBL] [Abstract][Full Text] [Related]
34. [The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer].
Han B; Liao M; Su J; Feng J; Wang E; Dong Q
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):727-31. PubMed ID: 12622891
[TBL] [Abstract][Full Text] [Related]
35. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
36. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
[TBL] [Abstract][Full Text] [Related]
37. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
38. [Application of ATP based bioluminescence tumor chemosensitivity assay in the chemotherapy of pediatric solid tumor].
Cheng HY; Zhu XD; Wang HM; Qin H
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):598-603. PubMed ID: 19951493
[TBL] [Abstract][Full Text] [Related]
39. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
Zhang T; Guan M; Jin HY; Lu Y
Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
[TBL] [Abstract][Full Text] [Related]
40. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
